Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.96 |
| ▸ | BACE1 | P56817 | 1/20 | 0.96 |
| ▸ | ALOX5 | P09917 | 15/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.51 |
| ▸ | GLS2 | Q9UI32 | 1/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | STAT3 | P40763 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | MPEG1 | Q2M385 | 7/20 | 0.40 |
| ▸ | XIAP | P98170 | 2/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | PTGES | O14684 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28564810 | 0.98 | ACHE (1.00) | ACHEBACE1ALOX5PTGS2GLS2 | |
| SCHEMBL10701374 | 0.98 | ACHE (1.00) | ACHEBACE1ALOX5PTGS2GLS2 | |
| SCHEMBL31203727 | 0.98 | ACHE (1.00) | ACHEBACE1ALOX5PTGS2GLS2 | |
| SCHEMBL3264783 | 0.98 | ACHE (1.00) | ACHEBACE1ALOX5PTGS2GLS2 | |
| SCHEMBL20875697 | 0.98 | ACHE (1.00) | ACHEBACE1ALOX5PTGS2GLS2 | |
| SCHEMBL10704172 | 0.98 | ACHE (1.00) | ACHEBACE1ALOX5PTGS2GLS2 | |
| SCHEMBL11018415 | 0.98 | ACHE (1.00) | ACHEBACE1ALOX5PTGS2GLS2 | |
| SCHEMBL10702354 | 0.98 | ACHE (1.00) | ACHEBACE1ALOX5PTGS2GLS2 | |
| SCHEMBL8782213 | 0.98 | ACHE (1.00) | ACHEBACE1ALOX5PTGS2GLS2 | |
| SCHEMBL28549544 | 0.98 | ACHE (1.00) | ACHEBACE1ALOX5PTGS2GLS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11311548-B2 | Cancer therapy | ASLAN PHARMACEUTICALS PTE. LTD. (SG) | 2022-04-26 | — | — | US | claimed |
| CN-110496163-A | The preparation method of citrous bud or flower or branch or leaf or fruit active component or ingredient and its application in medicine preparation | UNIV JIANGXI TRADITIONAL CHINESE MEDICINE | 2019-11-26 | — | — | CN | claimed |
| CN-108524511-A | Cancer therapy | 阿斯兰制药有限公司 | 2018-09-14 | — | — | CN | claimed |
| EP-0418278-A1 | PROCESS FOR THE PREPARATION OF (ARYLETHYL)HYDROQUINONES AND DIESTERS THEREOF | EASTMAN KODAK COMPANY (US) | 1991-03-27 | — | — | EP | claimed |
| WO-1989012037-A1 | PROCESS FOR THE PREPARATION OF (ARYLETHYL)HYDROQUINONES AND DIESTERS THEREOF | EASTMAN KODAK COMPANY (US) | 1989-12-14 | — | — | WO | claimed |
| US-20240307472-A1 | BEVERAGES CONTAINING NATURAL PRODUCTS | PK Beverages LLC (US) | 2024-09-19 | — | — | US | disclosed |
| US-20240245623-A1 | MODULAR TRANSDERMAL DELIVERY SYSTEM AND ASSOCIATED METHODS OF MANUFACTURE AND USE | PURE RATIOS HOLDING INC (US) | 2024-07-25 | — | — | US | disclosed |
| CN-117659025-A | TOLL-like receptor 8 (TLR 8) specific antagonists, methods of making and uses thereof | 科罗拉多州立大学董事会法人团体 | 2024-03-08 | — | — | CN | disclosed |
| CN-117586108-A | TOLL-like receptor 8 (TLR 8) specific antagonists, methods of making and uses thereof | 科罗拉多州立大学董事会法人团体 | 2024-02-23 | — | — | CN | disclosed |
| CN-117586191-A | TOLL-like receptor 8 (TLR 8) specific antagonists, methods of making and uses thereof | 科罗拉多州立大学董事会法人团体 | 2024-02-23 | — | — | CN | disclosed |
| CN-111542515-B | TOLL-like receptor 8 (TLR 8) specific antagonists, methods of making and uses thereof | 科罗拉多州立大学董事会法人团体 | 2023-12-05 | — | — | CN | disclosed |
| CN-116999424-A | Acyl quinic acid compound and application thereof | 陕西中医药大学 | 2023-11-07 | — | — | CN | disclosed |
| US-4306012-A | Process of radiation and heat treatment of printing medium | HERCULES INCORPORATED (US) | 1981-12-15 | — | — | US | disclosed |
| EP-0038092-A1 | Photographic material suited for use in diffusion transfer photography | AGFA-GEVAERT N.V. (BE) | 1981-10-21 | — | — | EP | disclosed |
| US-4272610-A | LITHOGRAPHIC PLATES | HERCULES INCORPORATED (US) | 1981-06-09 | — | — | US | disclosed |
| US-4271259-A | Photosensitive compositions containing a photooxidizable component | HERCULES INCORPORATED (US) | 1981-06-02 | — | — | US | disclosed |
| US-4198238-A | Photopolymerizable composition | HERCULES INCORPORATED (US) | 1980-04-15 | — | — | US | disclosed |
| US-4174218-A | CROSSLINKING ADDITION POLYMER WITH SATURATED MONOMER BY PHOTOPOLYMERIZATION | HERCULES INCORPORATED (US) | 1979-11-13 | — | — | US | disclosed |
| US-4137081-A | Printing plates from polymer with terminal unsaturation | HERCULES INCORPORATED (US) | 1979-01-30 | — | — | US | disclosed |
| US-4047963-A | ETHYLENE OXIDE COPOLYMER, UNSATURATED MONOMER, PHOTOINITIATOR | HERCULES INCORPORATED (US) | 1977-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11311548-B2 | Cancer therapy | DHODH, MCL1, DOHH | ACHE 3770/4885BACE1 3979/4885ALOX5 2190/4885 |
| US-20240307472-A1 | BEVERAGES CONTAINING NATURAL PRODUCTS | FABP3, SIRT3, SIRT5 | ACHE 3320/4885BACE1 3612/4885ALOX5 2533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.